Vascular Inflammation in Psoriasis - Extension Study

NCT01866592 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

81

Enrollment

OTHER

Sponsor class

Conditions

Psoriasis
Cardiovascular Disease

Interventions

DRUG: Adalimumab

Sponsor

University of Pennsylvania

Collaborators

[object Object]